Business Segments · Intangible Amortization
Biotechnology — Intangible Amortization
Danaher Biotechnology — Intangible Amortization increased by 1.7% to $234M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.9%, from $213M to $234M. Over 3 years (FY 2022 to FY 2025), Biotechnology — Intangible Amortization shows an upward trend with a 3.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026Apr 21, 2026
Rolls up toD&A
How to read this metric
High amortization often reflects significant past M&A activity and investment in proprietary technology.
Detailed definition
The periodic expense recognized for the consumption of intangible assets, such as patents, acquired technology, and cust...
Peer comparison
Standard for companies with high M&A activity in the life sciences sector.
Metric ID:
dhr_segment_biotechnology_amortization_of_intangible_assetsHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $203M | $203M | $203M | $203M | $216M | $216M | $216M | $216M | $218M | $214M | $218M | $213M | $213M | $228M | $231M | $230M | $234M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +6.4% | +0.0% | +0.0% | +0.0% | +0.9% | -1.8% | +1.9% | -2.3% | +0.0% | +7.0% | +1.3% | -0.4% | +1.7% |
| YoY Change | — | — | — | — | +6.4% | +6.4% | +6.4% | +6.4% | +0.9% | -0.9% | +0.9% | -1.4% | -2.3% | +6.5% | +6.0% | +8.0% | +9.9% |
Range$203M – $234M
CAGR+3.6%
Avg YoY Growth+4.1%
Median YoY Growth+6.4%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's biotechnology — intangible amortization?
- Danaher (DHR) reported biotechnology — intangible amortization of $234M in Q1 2026.
- How has Danaher's biotechnology — intangible amortization changed year-over-year?
- Danaher's biotechnology — intangible amortization increased by 9.9% year-over-year, from $213M to $234M.
- What is the long-term trend for Danaher's biotechnology — intangible amortization?
- Over 3 years (2022 to 2025), Danaher's biotechnology — intangible amortization has grown at a 3.6% compound annual growth rate (CAGR), from $812M to $902M.
- What does biotechnology — intangible amortization mean?
- The non-cash expense for the gradual write-off of acquired intangible assets.